MEDICAL PROGRESS Renal Failure in Cirrhosis

被引：560

作者：

Gines, Pere ^{[2
,3
]}

Schrier, Robert W. ^{[1
]}

机构：

[1] Univ Colorado Denver, Dept Med, Div Renal Dis & Hypertens, Aurora, CO USA

[2] Univ Barcelona, Hosp Clin Barcelona, Liver Unit, Barcelona, Catalonia, Spain

[3] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer, Barcelona, Catalonia, Spain

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2009年 / 361卷 / 13期

关键词：

SPONTANEOUS BACTERIAL PERITONITIS; LIVER-KIDNEY TRANSPLANTATION; TYPE-1; HEPATORENAL-SYNDROME; INTERNATIONAL-ASCITES-CLUB; SERUM CREATININE; NITRIC-OXIDE; RISK-FACTORS; ADRENAL INSUFFICIENCY; TERLIPRESSIN THERAPY; CONSENSUS CONFERENCE;

D O I：

10.1056/NEJMra0809139

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Renal failure is a very common, severe complication in patients with decompensated cirrhosis and is a risk factor for a poor outcome of liver transplantation. Recently introduced therapies have demonstrated efficacy in the prevention and management of the hepatorenal syndrome, a particularly severe form of renal failure characteristic of cirrhosis. Use of these therapies in patients awaiting liver transplantation may help improve the outcome after transplantation. Copyright © 2009 Massachusetts Medical Society. All rights reserved.

引用

页码：1279 / 1290

页数：12

共 100 条

[1] Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement [J].

Albillos, A ;

de la Hera, A ;

González, M ;

Moya, JL ;

Calleja, JL ;

Monserrat, J ;

Ruiz-del-Arbol, L ;

Alvarez-Mon, M .

HEPATOLOGY, 2003, 37 (01) :208-217

[2] MELD score and clinical type predict prognosis in hepatorenal syndrome:: Relevance to liver transplantation [J].

Alessandria, C ;

Ozdogan, O ;

Guevara, M ;

Restuccia, T ;

Jiménez, W ;

Arroyo, V ;

Rodés, J ;

Ginès, P .

HEPATOLOGY, 2005, 41 (06) :1282-1289

[3] Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide [J].

Angeli, P ;

Volpin, R ;

Gerunda, G ;

Craighero, R ;

Rone, P ;

Merenda, R ;

Amodio, P ;

Sticca, A ;

Caregaro, L ;

Maffei-Faccioli, A ;

Gatta, A .

HEPATOLOGY, 1999, 29 (06) :1690-1697

[4] Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis [J].

Angeli, Paolo ;

Merkel, Carlo .

JOURNAL OF HEPATOLOGY, 2008, 48 :S93-S103

[5]

[Anonymous], COCHRANE DATABASE SY

[6] Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis [J].

Arroyo, V ;

Gines, P ;

Gerbes, AL ;

Dudley, FJ ;

Gentilini, P ;

Laffi, G ;

Reynolds, TB ;

RingLarsen, H ;

Scholmerich, J .

HEPATOLOGY, 1996, 23 (01) :164-176

[7] Hepatorenal syndrome [J].

Bataller, R ;

Ginès, P ;

Guevara, M ;

Arroyo, V .

SEMINARS IN LIVER DISEASE, 1997, 17 (03) :233-247

[8] Results of combined and sequential liver-kidney transplantation [J].

Becker, T ;

Nyibata, M ;

Lueck, R ;

Bektas, H ;

Demirci, G ;

Lehner, F ;

Tusch, G ;

Strassburg, C ;

Schwarz, A ;

Klempnauer, J ;

Nashan, B .

LIVER TRANSPLANTATION, 2003, 9 (10) :1067-1078

[9] Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding:: A meta-analysis [J].

Bernard, B ;

Grangé, JD ;

Khac, EN ;

Amiot, X ;

Opolon, P ;

Poynard, T .

HEPATOLOGY, 1999, 29 (06) :1655-1661

[10] Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis [J].

Bories, PN ;

Campillo, B ;

Azaou, L ;

Scherman, E .

HEPATOLOGY, 1997, 25 (06) :1328-1333

← 1 2 3 4 5 6 7 8 9 10 →